Nexstim
8.4
EUR
+1.69 %
5,422 following
NXTMH
First North Finland
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Income statement
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 2.7 | 3.3 | 4.1 | 6.4 | 9.5 | 7.2 | 8.7 | 15.8 | 18.3 | 21.7 | 24.7 |
growth-% | 25.3 % | 22.9 % | 55.5 % | 48.9 % | -23.9 % | 20.5 % | 80.8 % | 16.1 % | 18.1 % | 14.0 % | |
EBITDA | -6.0 | -6.2 | -3.0 | -1.0 | 1.3 | -0.5 | 0.3 | 4.4 | 5.3 | 7.4 | 8.0 |
EBIT (adj.) | -6.3 | -6.5 | -3.3 | -1.5 | 0.8 | -1.2 | -0.5 | 3.4 | 4.2 | 6.3 | 6.9 |
EBIT | -6.3 | -6.5 | -3.3 | -1.5 | 0.8 | -1.2 | -0.5 | 3.4 | 4.2 | 6.3 | 6.9 |
Profit before taxes | -6.2 | -6.8 | -4.1 | -0.7 | 1.3 | -1.3 | -0.9 | 3.4 | 3.9 | 6.2 | 6.8 |
Net income | -6.2 | -6.8 | -4.1 | -0.8 | 1.3 | -1.3 | -0.9 | 3.4 | 3.9 | 6.2 | 6.1 |
EPS (adj.) | -1.89 | -0.11 | -0.01 | -0.11 | 0.18 | -0.18 | -0.12 | 0.48 | 0.55 | 0.87 | 0.86 |
growth-% | -201.5 % | 14.6 % | 57.8 % | -1.1 % | |||||||
Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.21 |
Dividend ratio | 25.0 % |
Profitability and return on capital
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
EBITDA-% | -224.4 % | -185.7 % | -72.1 % | -15.8 % | 13.8 % | -7.3 % | 3.7 % | 27.9 % | 28.7 % | 34.2 % | 32.4 % |
EBIT-% (adj.) | -236.4 % | -194.7 % | -81.0 % | -22.7 % | 8.8 % | -16.9 % | -6.1 % | 21.7 % | 23.1 % | 29.3 % | 28.0 % |
EBIT-% | -236.4 % | -194.7 % | -81.0 % | -22.7 % | 8.8 % | -16.9 % | -6.1 % | 21.7 % | 23.1 % | 29.3 % | 28.0 % |
ROE | 1,312.0 % | 373.1 % | -96.0 % | 36.0 % | -38.5 % | -35.8 % | 93.2 % | 53.4 % | 49.9 % | 33.0 % | |
ROI | -96.5 % | -73.1 % | -27.2 % | 11.4 % | -16.6 % | -5.4 % | 26.3 % | 31.6 % | 41.3 % | 33.6 % |
Valuation
2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025e | 2026e | 2027e | 2028e | |
---|---|---|---|---|---|---|---|---|---|---|---|
Share price (EUR) | 0.60 | 0.12 | 0.10 | 4.78 | 4.00 | 2.69 | 7.90 | 8.40 | 8.40 | 8.40 | 8.40 |
Shares | 3.3 | 62.8 | 439.6 | 7.3 | 7.3 | 7.3 | 7.2 | 7.2 | 7.2 | 7.2 | 7.2 |
Market cap | 2.0 | 7.5 | 43.1 | 34.8 | 29.1 | 19.6 | 56.6 | 60.2 | 60.2 | 60.2 | 60.2 |
Enterprise value | 3.0 | 9.5 | 44.7 | 33.5 | 28.1 | 22.5 | 63.2 | 64.1 | 60.0 | 53.6 | 46.8 |
EV/S | 1.1 | 2.9 | 10.9 | 5.2 | 3.0 | 3.1 | 7.2 | 4.1 | 3.3 | 2.5 | 1.9 |
EV/EBITDA | - | - | - | - | 21.4 | - | 195.4 | 14.6 | 11.4 | 7.2 | 5.8 |
EV/EBIT (adj.) | - | - | - | - | 33.6 | - | - | 18.7 | 14.2 | 8.5 | 6.8 |
EV/EBIT | - | - | - | - | 33.6 | - | - | 18.7 | 14.2 | 8.5 | 6.8 |
P/E (adj.) | - | - | - | - | 22.2 | - | - | 17.5 | 15.3 | 9.7 | 9.8 |
P/E | - | - | - | - | 22.2 | - | - | 17.5 | 15.3 | 9.7 | 9.8 |
P/B | - | - | - | 10.9 | 7.1 | 6.9 | 28.8 | 11.2 | 6.5 | 3.9 | 2.8 |
P/S | 0.7 | 2.3 | 10.5 | 5.4 | 3.1 | 2.7 | 6.5 | 3.8 | 3.3 | 2.8 | 2.4 |
Dividend yield | 2.6 % | ||||||||||
Equity ratio | -3.0 % | -9.7 % | -23.5 % | 31.9 % | 39.8 % | 28.6 % | 13.8 % | 32.8 % | 56.5 % | 73.2 % | 77.7 % |
Gearing ratio | -371.7 % | -271.7 % | -108.1 % | -40.6 % | -23.4 % | 105.6 % | 336.8 % | 73.5 % | -1.8 % | -41.9 % | -61.6 % |
Quarter data
Q1/24 | Q2/24 | Q3/24 | Q4/24 | 2024 | Q1/25e | Q2/25e | Q3/25e | Q4/25e | |
---|---|---|---|---|---|---|---|---|---|
Revenue | 3.2 | 5.6 | 8.7 | 5.6 | 10.2 | ||||
EBITDA | -0.5 | 0.8 | 0.3 | 0.2 | 4.6 | 0.2 | -0.7 | ||
EBIT | -0.9 | 0.3 | -0.5 | 4.4 | -0.9 | ||||
Profit before taxes | -0.9 | 0.1 | -0.9 | 4.4 | -0.9 | ||||
Net income | -0.9 | 0.1 | -0.9 | 4.4 | -0.9 |